4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-111812
Co-Chief Executive Officer sold 18,589 shares at $3.20 ($59,429)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2024-09-30 | Sale | −18,589 | $3.20 | $59,429 | 3,120,569 | D |
| Open-market sales · 18,589 sh · avg $3.20 · $59,429 | |||||||
Loading xslF345X05/ownership.xml…